Gabriele Bianco Selected Research

Bacterial Eye Infections

3/2021

Bacterial etiology and antimicrobial resistance trends in ocular infections: A 30-year study, Turin area, Italy.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Gabriele Bianco Research Topics

Disease

6	Infections 05/2022 - 12/2018
4	Sepsis (Septicemia) 09/2022 - 05/2020
4	Pneumonia (Pneumonitis) 10/2021 - 11/2020
3	COVID-19 05/2022 - 01/2021
2	Critical Illness (Critically Ill) 01/2022 - 02/2021
2	Human Influenza (Influenza) 10/2021 - 11/2020
1	Aspergillosis 10/2021
1	Conjunctivitis 03/2021
1	Keratitis 03/2021
1	Endophthalmitis (Ophthalmia) 03/2021
1	Bacterial Eye Infections 03/2021
1	Rubella (German Measles) 09/2019
1	Suppuration 01/2019
1	Bacteremia 12/2018
1	Viremia 10/2018

Drug/Important Bio-Agent (IBA)

5	ceftazidime drug combination avibactamIBA 09/2022 - 05/2020
4	carbapenemaseIBA 04/2022 - 10/2020
3	meropenem and vaborbactamIBA 09/2022 - 01/2022
3	Anti-Bacterial Agents (Antibiotics)IBA 05/2022 - 02/2021
3	DNA (Deoxyribonucleic Acid)IBA 04/2020 - 10/2018
2	CefiderocolIBA 09/2022 - 04/2022
2	Immunoglobulin G (IgG)IBA 09/2019 - 01/2019
1	tazobactam drug combination ceftolozaneIBA 09/2022
1	Aztreonam FDA LinkGeneric 04/2022
1	TriazolesIBA 10/2021
1	CoagulaseIBA 03/2021
1	Chloramphenicol (Chloromycetin)FDA Link 03/2021
1	Tetracycline (Achromycin)FDA LinkGeneric 03/2021
1	Ampicillin (Omnipen)FDA LinkGeneric 03/2021
1	FluoroquinolonesIBA 03/2021
1	AminoglycosidesIBA 03/2021
1	AntigensIBA 01/2021
1	Immunoglobulin M (IgM)IBA 01/2019

Therapy/Procedure

4	Therapeutics 01/2022 - 01/2020
3	Noninvasive Ventilation 10/2021 - 11/2020
1	Terminal Care (Care, Terminal) 11/2020
1	Oral Hygiene (Dental Hygiene) 12/2018
1	Transplantation 10/2018